Influence of various cytokines on the expression of CD20 on the surface of CLL-cells in vitro.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0145-2126(00)00098-9PMID 11203684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia.

  2000cited by this paper
• Induction of apoptosis using 2′,2′difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells

  2000cited by this paper
• Induction of Apoptosis by 2-Chloro-2'deoxyadenosine (2-CdA) Alone and In Combination with other Cytotoxic Drugs: Synergistic Effects on Normal and Neoplastic Lymphocytes by Addition of Doxorubicin and Mitoxantrone

  2000cited by this paper
• Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.

  2000cited by this paper
• Levels of expression of CD19 and CD20 in chronic B cell leukaemias.

  1998cited by this paper
• Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.

  1997cited by this paper
• Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators.

  1996cited by this paper

• The Role of Neutrophils in the Pathogenesis of Chronic Lymphocytic Leukemia

  2021cites this paper
• Development of Novel Anti-Cd20 Monoclonal Antibodies and Modulation in Cd20 Levels on Cell Surface: Looking to Improve Immunotherapy Response

  2015cites this paper
• Improvement of Rituximab Efficiency in Chronic Lymphocytic Leukemia by CpG‐Mediated Upregulation of CD20 Expression Independently of PU.1

  2009cites this paper
• Regulation of CD20 expression by radiation-induced changes in intracellular redox status.

  2008cites this paper
• Clinical uses of GM-CSF, a critical appraisal and update

  2008cites this paper
• Richter's syndrome: biology and therapy.

  2005cites this paper
• Clinical flow cytometry: a transition in utilization.

  2004cites this paper
• Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte‐macrophage–colony stimulating factor (GM‐CSF) alternating with methotrexate and cytarabine plus rituximab and GM‐CSF in patients with Richter syndrome or fludarabine‐refractory chroni

  2003cites this paper
• Advances in classification and therapy of indolent B-cell malignancies.

  2002cites this paper
• Advances in classification and therapy of indolent B-cell malignancies.

  2002cites this paper